In-Depth Characterization of Live Vaccines Used in Europe for Oral Rabies Vaccination of Wildlife

被引:15
作者
Cliquet, Florence [1 ]
Picard-Meyer, Evelyne [1 ]
Mojzis, Miroslav [2 ]
Dirbakova, Zuzana [2 ]
Muizniece, Zita [3 ]
Jaceviciene, Ingrida [4 ,5 ]
Mutinelli, Franco [6 ]
Matulova, Marta [7 ]
Frolichova, Jitka [8 ]
Rychlik, Ivan [7 ]
Celer, Vladimir [8 ]
机构
[1] ANSES, Malzeville, France
[2] State Vet & Food Inst Zvolen, Zvolen, Slovakia
[3] Inst Food Safety Anim Hlth & Environm BIOR, Riga, Latvia
[4] Natl Food & Vet Risk Assessment Inst Lithuania, Vilnius, Lithuania
[5] Univ Appl Sci, Fac Agrotechnol, Vilnius, Lithuania
[6] Ist Zooprofilatt Sperimentale Venezie, Padua, Italy
[7] Vet Res Inst, CS-62132 Brno, Czech Republic
[8] Univ Vet & Pharmaceut Sci Brno, Dept Infect Dis & Microbiol, Brno, Czech Republic
关键词
D O I
10.1371/journal.pone.0141537
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Although rabies incidence has fallen sharply over the past decades in Europe, the disease is still present in Eastern Europe. Oral rabies immunization of wild animal rabies has been shown to be the most effective method for the control and elimination of rabies. All rabies vaccines used in Europe are modified live virus vaccines based on the Street Alabama Dufferin (SAD) strain isolated from a naturally-infected dog in 1935. Because of the potential safety risk of a live virus which could revert to virulence, the genetic composition of three commercial attenuated live rabies vaccines was investigated in two independent laboratories using next genome sequencing. This study is the first one reporting on the diversity of variants in oral rabies vaccines as well as the presence of a mix of at least two different variants in all tested batches. The results demonstrate the need for vaccine producers to use new robust methodologies in the context of their routine vaccine quality controls prior to market release.
引用
收藏
页数:8
相关论文
共 21 条
[1]  
[Anonymous], 2013, WHO EXP CONS RAB
[2]  
[Anonymous], 2013, RABIES
[3]  
[Anonymous], EFSA J
[4]   Ultra-Deep Sequencing of Intra-host Rabies Virus Populations during Cross-species Transmission [J].
Borucki, Monica K. ;
Chen-Harris, Haiyin ;
Lao, Victoria ;
Vanier, Gilda ;
Wadford, Debra A. ;
Messenger, Sharon ;
Allen, Jonathan E. .
PLOS NEGLECTED TROPICAL DISEASES, 2013, 7 (11)
[5]   Next-generation sequencing technology in clinical virology [J].
Capobianchi, M. R. ;
Giombini, E. ;
Rozera, G. .
CLINICAL MICROBIOLOGY AND INFECTION, 2013, 19 (01) :15-22
[6]  
Cliquet F, 2004, DEV BIOLOGICALS, V119, P185
[7]   Rabies in Europe: what are the risks? [J].
Cliquet, Florence ;
Picard-Meyer, Evelyne ;
Robardet, Emmanuelle .
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2014, 12 (08) :905-908
[8]   Genetic strain modification of a live rabies virus vaccine widely used in Europe for wildlife oral vaccination [J].
Cliquet, Florence ;
Robardet, Emmanuelle ;
Meyer, Evelyne Picard .
ANTIVIRAL RESEARCH, 2013, 100 (01) :84-89
[9]  
EDQM, 2013, EDQM MON, V0451, P1008
[10]  
EDQM, 2014, EDQM MON, V0746, P1011